- Home
- PRQR vs FT Comparison
PRQR vs FT Comparison
Compare PRQR & FT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRQR
- FT
- Stock Information
- Founded
- PRQR 2012
- FT 1988
- Country
- PRQR Netherlands
- FT United States
- Employees
- PRQR N/A
- FT N/A
- Industry
- PRQR Biotechnology: Pharmaceutical Preparations
- FT Trusts Except Educational Religious and Charitable
- Sector
- PRQR Health Care
- FT Finance
- Exchange
- PRQR Nasdaq
- FT Nasdaq
- Market Cap
- PRQR 179.1M
- FT 187.3M
- IPO Year
- PRQR 2014
- FT N/A
- Fundamental
- Price
- PRQR $1.94
- FT $7.54
- Analyst Decision
- PRQR Strong Buy
- FT
- Analyst Count
- PRQR 7
- FT 0
- Target Price
- PRQR $9.00
- FT N/A
- AVG Volume (30 Days)
- PRQR 302.0K
- FT 63.0K
- Earning Date
- PRQR 08-07-2025
- FT 01-01-0001
- Dividend Yield
- PRQR N/A
- FT 7.85%
- EPS Growth
- PRQR N/A
- FT N/A
- EPS
- PRQR N/A
- FT N/A
- Revenue
- PRQR $21,212,711.00
- FT N/A
- Revenue This Year
- PRQR $2.87
- FT N/A
- Revenue Next Year
- PRQR N/A
- FT N/A
- P/E Ratio
- PRQR N/A
- FT N/A
- Revenue Growth
- PRQR 85.91
- FT N/A
- 52 Week Low
- PRQR $1.07
- FT $5.97
- 52 Week High
- PRQR $4.62
- FT $7.23
- Technical
- Relative Strength Index (RSI)
- PRQR 63.06
- FT 57.92
- Support Level
- PRQR $1.77
- FT $7.42
- Resistance Level
- PRQR $1.96
- FT $7.53
- Average True Range (ATR)
- PRQR 0.10
- FT 0.06
- MACD
- PRQR 0.01
- FT -0.00
- Stochastic Oscillator
- PRQR 80.78
- FT 100.00
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
About FT Franklin Universal Trust
Franklin Universal Trust is a closed-end management investment company. Its primary investment objective is to provide high, current income consistent with the preservation of capital. Its secondary objective is the growth of income through dividend increases and capital appreciation. The fund invests in two asset classes being the high yield bonds and utility stocks.